Opioid Use Down With High-Frequency Electrical Stimulation Device After C-Section
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Oct. 20, 2023 -- Use of a high-frequency electrical stimulation device after cesarean delivery is associated with reduced opioid use, according to a study published online Oct. 20 in JAMA Network Open.
Jennifer L. Grasch, M.D., from The Ohio State University Wexner Medical Center in Columbus, and colleagues conducted a randomized clinical trial from April 18, 2022, to Jan. 31, 2023, in the labor and delivery unit at a single tertiary academic medical center. Individuals with a singleton or twin delivery who underwent cesarean delivery were eligible for the study; 134 were included. Participants were randomly assigned to a high-frequency (20,000 Hz) electrical stimulation device group or to an identical-appearing sham device group in a 1:1 ratio (67 participants in each group) and received three applications at the incision site.
The researchers found that compared with individuals in the sham device group, those assigned to the functional device used significantly less opioid medication prior to discharge (median, 19.75 versus 37.50 morphine milligram equivalents [MME]) and they reported similar rates of moderate-to-severe pain and mean pain scores. Fewer MME were prescribed at discharge for participants in the functional device group (median, 82.50 versus 90.00). In addition, compared with the sham group, those in the functional device group were more likely to be discharged without an opioid prescription (25 versus 10 percent; relative risk, 1.58). Neither group reported any treatment-related adverse events.
"Future studies focused on integrating device use into routine care and in other settings are needed to confirm the feasibility and generalizability of these findings," the authors write.
One author disclosed ties to the health care industry; the study was funded by TrueRelief.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
American College of Obstetricians and Gynecologists, May 17-19
The annual meeting of the American College of Obstetricians and Gynecologists was held from May 17 to 19 in San Francisco and was attended by more than 4,000 clinicians...
Epidural Analgesia Linked to Decline in Severe Maternal Morbidity
FRIDAY, May 24, 2024 -- Epidural analgesia during labor is associated with a reduction in severe maternal morbidity (SMM), according to a study published online May 22 in The...
High Predictability for Measles Antibody Dynamics Discernible From Birth
MONDAY, May 13, 2024 -- At the individual level, there is high predictability for measles antibody dynamics from birth, according to a study published online May 13 in Nature...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.